TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT02966002

Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“This study was terminated due to inability to recruit sufficient patients.”

The sponsor’s own words in the registry.

Life of this trial

2016201720182019Started2016-04Registered2016-11-15Stopped2017-05-25Results posted2018-05-18

Vital statistics

Status
Terminated
Phase
Phase 4
Sponsor
University of Michigan
Sponsor type
University, hospital or other
Conditions
Fontan Procedure
Interventions
Aspirin
Participants
9
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.